Updated
Reviewed
Management of Children Receiving Antiretroviral Therapy
Overview
In the United States, the majority of children with HIV are receiving antiretroviral therapy (ART), making treatment-experienced children the norm. Providers may consider antiretroviral (ARV) regimen changes for the following reasons:
- Treatment simplification: Modifying ARV regimens in children who are currently receiving effective ART in order to simplify the regimen.
- Treatment optimization: Increasing the treatment potency or barrier to resistance of an effective but older or potentially fragile regimen or improving the adverse event profile.
- Toxicity management: Recognizing and managing ARV drug toxicity or intolerance (see Management of Medication Toxicity or Intolerance).
- Treatment failure: Recognizing and managing treatment failure (see Recognizing and Managing Antiretroviral Treatment Failure).
Download Guidelines
- Full Guideline PDF (6.91 MB)
- Recommendations Only PDF (226.89 KB)
- Tables Only PDF (1.29 MB)
- Drug Tables Only PDF (2.38 MB)